Where is the manufacturing plant located?

The company is located at 13-3 Guanshan Road, Yuhang District, Hangzhou, Zhejiang, China, with a plant area of 12,000 square meters.

What is the production capacity for recombinant antigens?

The production capacity for recombinant antigens has reached 18g per month.

What main products does Testsea Biotechnology offer?

Main products include Infectious Disease Rapid Tests, Drug of Abuse Tests, Animal Diagnostic Tests, Hormone Tests, Tumor Markers, Cardiac Markers, Food Safety Tests, Reagents, and Medical Machines.

B Rapid Test Kit

Name: Testsealabs CE/White List Approved Flu A/B Rapid Test Kit
Brand: HangZhou Testsea biotechnology Co., Ltd.
SKU: 2188093475

Zhejiang, ChinaHangZhou Testsea biotechnology Co., Ltd.

US$2.20

1,000-4,999 Pieces

US$2.00

5,000+ Pieces

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Type

IVD Instrument

Certificate

ISO9001, ISO13485, CE

Model NO.

Cassette

Shelf life

2 Years

OEM

Support

Transport Package

Carton

Specification

25tests/box

Trademark

TESTSEALABS

Origin

China

HS Code

3822190020

Production Capacity

100000000

Key features

CE & White List Approved: Product holds CE certification and is on the White List for reliable diagnostic performance.

High Production Capacity: Recombinant antigen production capacity reaches 18g per month for stable supply.

GMP Purification Workshop: Features a 2,000 square meter GMP 100,000-level purification workshop for quality control.

OEM/ODM Support: Supports OEM and ODM services with 9 R&D engineers and advanced assembly machines.

ISO Certified Quality: Strictly follows ISO13485 and ISO9001 quality management systems for all operations.

2-Year Shelf Life: Products are guaranteed with a shelf life of 2 years for long-term storage stability.

Strong R&D Team: Led by doctors and masters from Zhejiang University with 28 applied patents.

Global Market Reach: Exports to North America, Europe, Africa, and Southeast Asia with established relationships.

Company profile

HangZhou Testsea biotechnology Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2022-04-08Nearest Port: Shanghai, Ningbo, ShenzhenAverage Response Time: ≤9.25h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryTestsea Biotechnology is identified as a China-based limited company in Hangzhou, with records describing it as both a trading company and manufacturer/factory. Its stated capabilities include in-vitro diagnostic, veterinary, rapid-test, reagent, and medical-machine products. The supplier reports ISO 9001 and GMP certification, more than 10 production lines, 50 R&D engineers, 50 quality-control staff, and exports to multiple global regions. It describes three technical platforms and sales coverage exceeding 100 countries and regions. However, the evidence does not establish after-sales performance, financial credibility, or product-customization capability. One record associates the supplier with a 2025 THC urine-test product and a Vietnamese buyer, but this is limited customer evidence and does not independently verify broader performance.

Supplier typeThe supplier is identified as a limited company headquartered in Hangzhou, China, and is described as both a trading company/manufacturer-factory. A separate record characterizes the company nature as a factory, supporting a manufacturing role alongside trading activity.

CertificationsThe supplier reports ISO 9001 and GMP certification under its management-system certifications. These are explicit certifications relevant to quality and manufacturing controls.

R&D capabilityThe supplier states that it develops core innovative raw-material technologies and has established immunological detection, molecular-biology detection, and protein core-sheet inspection platforms. The reported 50 R&D engineers and continuing R&D investment further support an established innovation function.

Production capacityThe supplier reports more than 10 production lines, 50 quality-control staff, a one-month off-peak lead time, and broad diagnostic-product offerings. It also reports 90% export sales and access to Shanghai, Ningbo, and Shenzhen ports, although the stated peak-season fulfillment time of 6–12 months indicates substantial seasonal capacity constraints.

Client casesThe supplier states that its products have been sold in more than 100 countries and regions. A separate record identifies a THC urine-test product and one associated Vietnamese buyer, but it does not provide verifiable case details such as order scale, duration, performance results, or references.